See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 2, 2005

Skin Cancer Common Cold Myasthenia Gravis Generalized

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Skin Cancer

This trial will study STA-4783, a taxane potentiator that enhances the antitumor response of paclitaxel. Participants must be male or female 18 years of age or older with histologically confirmed metastatic (Stage IV) melanoma, and must be willing to sign a written informed consent document. Research sites located in Connecticut, Missouri and Alabama.

More Information

Please see http://www.centerwatch.com/patient/studies/cat37.html.

-----

Common Cold

UVA Health System Department of Otolaryngology seeks adults with a new cold for a cold study. Participants must have a very runny nose. Study requires an overnight stay in a local hotel. Compensation is $200. Research site located in Charlottesville, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat405.html.

-----

Myasthenia Gravis Generalized

The efficacy and safety of CellCept will be assessed in patients with myasthenia gravis receiving prednisone, or other corticosteroids. During the study, patients will undergo gradual corticosteroid dose reduction, if they respond to treatment. Qualified participants will be adults 18 to 80 with a diagnosis of myasthenia gravis and a history of myasthenia weakness involving more than ocular (eye) or peri-ocular muscle. Research sites located throughout the United States, Germany, Czech Republic, Canada, Israel, Netherlands, Ukraine, and Great Britain.

More Information

Please see http://www.centerwatch.com/patient/studies/cat674.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.